Sodium tetradecyl sulfate

Sodium tetradecyl sulfate

Clinical data
AHFS/Drugs.com	Consumer Drug Information
Routes of administration	Intravenous injection
ATC code	C05BB04 (WHO)
Legal status
Legal status	Prescription only medicine
Identifiers
IUPAC name Sodium tetradecylsulfate
PubChem CID	14492
UNII	Q1SUG5KBD6
ChEMBL	ChEMBL1200354 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C14H29NaO4S
Molar mass	316.43243 g/mol
NY (what is this?)  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Sodium tetradecyl sulfate (STS) is an anionic surfactant used in the sclerosant drug Sotradecol. It is commonly used in the treatment of varicose and spider veins of the leg, during the procedure of sclerotherapy. Being a detergent-based chemical, its action is on the lipid molecules in the cells of the vein wall, causing inflammatory destruction of the internal lining of the vein and thrombus formation eventually leading to sclerosis of the vein. It is used in concentrations ranging from 0.1% to 3% for this purpose. In the UK, Ireland, Italy, Australia, New Zealand and South Africa, it is sold under the trade-name Fibro-Vein in concentrations of 0.2%, 0.5%, 1.0%, and 3%.

As of 30 October 2009, it has been claimed that it can also stop snoring when injected into the roof of the mouth by hardening the soft tissues which vibrate.

References

Template:Vasoprotectives